Agilon Health (AGL) Receivables (2020 - 2026)

Agilon Health (AGL) has 7 years of Receivables data on file, last reported at $899.7 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 27.42% year-over-year to $899.7 million; the trailing twelve-month figure through Mar 2026 stood at $899.7 million (down 27.42% YoY), and the FY2025 full-year result was $673.8 million, down 33.75% from the prior year.
• Receivables for Q1 2026 stood at $899.7 million, up from $673.8 million in the prior quarter.
• Across five years, Receivables topped out at $1.6 billion in Q1 2024 and bottomed at $499.3 million in Q4 2022.
• The 5-year median for Receivables is $1.0 billion (2023), against an average of $1.0 billion.
• The widest annual swing landed in 2023, when Receivables jumped 133.21%; it then sank 33.75% in 2025.
• A 5-year view of Receivables shows it stood at $499.3 million in 2022, then soared by 89.69% to $947.1 million in 2023, then rose by 7.39% to $1.0 billion in 2024, then tumbled by 33.75% to $673.8 million in 2025, then surged by 33.53% to $899.7 million in 2026.
• The last three Receivables figures came in at $899.7 million (Q1 2026), $673.8 million (Q4 2025), and $947.2 million (Q3 2025), per Business Quant data.

Peer Comparison